CAPSTONE® Spinal System 2991222Recalls & reported problems
Medtronic Sofamor Danek, Inc. · SPACER 2991222 CAPSTONE PEEK 12X22 · Class 2 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00613994290960), received between Oct 5, 2017 and Oct 21, 2024 — classified as 4 injuries.
The most frequently reported specific device problem is “Migration or Expulsion of Device” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
- Migration or Expulsion of Device1
Patient problems
- Apnea1
- Encephalopathy1
- Fever1
- Neuropathy1
- No Known Impact Or Consequence To Patient1
- Pain1
- Post Operative Wound Infection1
- Unspecified Infection1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryOct 21, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
INFORMATION WAS RECEIVED FROM MULTIPLE SOURCES (MANUFACTURER REPRESENTATIVE, HEALTHCARE PROVIDER, CLINICAL STUDY) REGARDING AN EVENT WHICH OCCURRED POST A CLINICAL STUDY (STUDY ID: (B)(4)) SPINAL FUSION PROCEDURE IN A PATIENT (PATIENT ID: (B)(6)). IT WAS REPORTED THAT PATIENT REPORTS LOW BACK PAIN AND RATES IT A 6-7 OUT OF 10. MILD PAIN WITH RANGE OF MOTION. PI STATES PROBABILITY OF MILD DISC STRAIN AND COMPLETED A STEROID INJECTION. REFILLED DICLOFENAC AND FLEXERIL FOR PAIN CONTROL. PRESCRIBED PHYSICAL THERAPY AND IF NO IMPROVEMENTS IN 6-8 WEEKS, THEN WILL SEND FOR AN MRI. PATIENT ALSO HAD ACUTE CYSTITIS, HYPOXIC-ISCHEMIC ENCEPHALOPATHY, LUMBAR RADICULOPATHY, SEVERE OBSTRUCTIVE SLEEP APNEA. NO PRODUCT MALFUNCTION REPORTED. SPONSOR ASSESSMENT: NOT RELATED TO PROCEDURE, POSSIBLE TO TLIF GRAFTING MATERIAL (AUTOGRAFT), BODY FUSION DEVICE (CAPSTONE), AND POSTERIOR SUPPLEMENTAL FIXATION SYSTEM. THERE WERE NO FURTHER COMPLICATIONS REPORTED REGARDING THE EVENT.ENT.
Patient problems: Apnea; Encephalopathy; Neuropathy; Pain
MAUDE report 20492254 ↗InjuryFeb 7, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
INFORMATION WAS RECEIVED FROM A REGULATORY BODY VIA MANUFACTURER REPRESENTATIVE REGARDING A PATIENT WITH AN UNKNOWN INDICATION FOR SPINAL THERAPY. IT WAS REPORTED THAT POSTERIOR LUMBAR DECOMPRESSION, BONE GRAFTING, FUSION AND INTERNAL FIXATION WERE PERFORMED ON (B)(6) 2023. LUMBAR 4, LUMBAR 5, AND SACRAL 1 PEDICLES WERE IMPLANTED, WITH A TOTAL OF 6 CROSSLINKS. A FUSION CAGE WAS IMPLANTED BETWEEN THE FOURTH AND FIFTH LUMBAR VERTEBRAE. WOUND INFECTION WAS FOUND ON (B)(6) 2023, AND A POSTERIOR LUMBAR DEBRIDEMENT, SUTURE, PERFUSION, IRRIGATION AND DRAINAGE WAS PERFORMED. THE PATIENT HAD A HYPERSENSITIVE CONSTITUTION, WAS ALLERGIC TO CEPHALOSPORIN ANTIBIOTICS, AND THE ANTIBIOTICS USED TO PREVENT INFECTION WERE NOT STRONG ENOUGH.
Patient problems: Post Operative Wound Infection
MAUDE report 18656825 ↗InjuryMar 16, 2018Migration or Expulsion of Device; Migration or Expulsion of Device
INITIAL PROCEDURE: POSTERIOR LUMBAR INTERBODY FUSION PRE-OP DIAGNOSIS: CAGE BETWEEN THE L2/3 BACKED-OUT AND L2 SCREW LOOSENED IT WAS REPORTED THAT ON AN UNKNOWN DATE, POST-OP, THE CAGE BETWEEN L2/3 BACKED OUT AND THE S4 SCREW ON L2 LOOSENED. NO BREAKAGE OF PRODUCTS WAS REPORTED. AN ADDITIONAL SURGERY WAS PLANNED TO BE PERFORMED ON (B)(6). NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THE EVENT.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7344223 ↗InjuryOct 5, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT PATIENT UNDERWENT POSTERIOR LUMBAR FUSION DUE TO DISC HERNIATION. POST-OP, INTER-VERTEBRAL SPACE INFECTION WAS OBSERVED ACCOMPANIED BY FEVER DISCOMFORT. PATIENT WAS HOSPITALIZED. PRODUCTS REMAIN IN THE PATIENT'S BODY. POST-OPERATIVE DEBRIDEMENT SURGERY WAS PERFORMED.
Patient problems: Fever; Unspecified Infection
MAUDE report 6916562 ↗
Other Intervertebral fusion device with bone graft, lumbar devices
- T-PAL 03.812.003Synthes GmbH · Intervertebral fusion device with bone graft, lumbar152 reports
- T-PAL 03.812.004Synthes GmbH · Intervertebral fusion device with bone graft, lumbar120 reports
- Catalyft PL Expandable Interbody System 6068073Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall66 reports
- Catalyft PL Expandable Interbody System 6069076Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall51 reports
- Catalyft PL Expandable Interbody System 6068076Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall46 reports
- EIT TLIF Inserter TFT30101EIT Emerging Implant Technologies GmbH · Intervertebral Fusion Device With Bone Graft, Lumbar88 reports
- T-PAL 03.812.001Synthes GmbH · Intervertebral fusion device with bone graft, lumbar76 reports
- Catalyft PL Expandable Interbody System 6069096Medtronic Sofamor Danek, Inc. · Intervertebral fusion device with bone graft, lumbar1 recall25 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page